Supernus Pharmaceuticals, Inc.

Patent Owner

Compare Create Portfolio
1Status Updates

Stats

Details

Technologies

Intl Class Technology # of Patents/ App Rank in Class
 
 
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 60186
 
 
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 1083
 
 
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 283
 
 
 
B05D PROCESSES FOR APPLYING LIQUIDS OR OTHER FLUENT MATERIALS TO SURFACES, IN GENERAL 291
 
 
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 2145
 
 
 
A61F FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS 1124
 
 
 
B65B MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING 158
 
 
 
C07C ACYCLIC OR CARBOCYCLIC COMPOUNDS 1124
 
 
 
C07D HETEROCYCLIC COMPOUNDS 1145

Top Patents (by citation)

Upgrade to the Premium Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2014/0187,552 METHOD OF TREATMENT OF AGGRESSIONJul 26, 13Jul 03, 14[A61K]
2014/0135,326 METHOD OF TREATMENT OF AGGRESSIONNov 13, 13May 15, 14[A61K]
2014/0100,219 MODIFIED RELEASE PREPARATIONS CONTAINING OXCARBAZEPINE AND DERIVATIVES THEREOFDec 11, 13Apr 10, 14[A61K]
2014/0037,745 CONTROLLED RELEASE COMPOSITIONS OF GAMMA-HYDROXYBUTYRATESep 24, 13Feb 06, 14[A61K]
2013/0202,661 FORMULATIONS OF VILOXAZINEFeb 07, 13Aug 08, 13[A61K]
2013/0089,607 ONCE DAILY TROSPIUM CHLORIDE TREATMENT METHODSep 19, 12Apr 11, 13[A61K]
2013/0011,483 FORMULATIONS OF MAZINDOLMar 30, 11Jan 10, 13[A61P, A61K]
2012/0321,708 SUSTAINED-RELEASE FORMULATIONS OF TOPIRAMATEAug 27, 12Dec 20, 12[A61P, A61K]
2012/0302,615 METHOD OF TREATMENT OF CNS DISORDERSDec 02, 10Nov 29, 12[A61P, A61K]
2012/0231,085 CONTROLLED RELEASE COMPOSITIONS OF GAMMA-HYDROXYBUTYRATEMay 21, 12Sep 13, 12[A61P, A61K]

View all Publication..

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
8,747,897 Osmotic drug delivery systemApr 27, 06Jun 10, 14[A61K]
8,748,472 Stabilized formulations of CNS compoundsMar 30, 11Jun 10, 14[A61K]
8,709,476 Compositions of quaternary ammonium compounds containing bioavailability enhancersNov 04, 04Apr 29, 14[A61K]
8,709,478 Once daily formulations of tetracyclinesJun 18, 13Apr 29, 14[A61K]
8,663,683 Sustained-release formulations of topiramateAug 27, 12Mar 04, 14[A61P, A61K]
8,617,600 Modified release preparations containing oxcarbazepine and derivatives thereofMay 21, 12Dec 31, 13[A61K]
8,598,191 Controlled release compositions of gamma-hydroxybutyrateMay 21, 12Dec 03, 13[A61K]
8,470,364 Once daily formulations of tetracyclinesDec 17, 10Jun 25, 13[A61K]
8,394,405 Once daily formulations of tetracyclinesDec 17, 10Mar 12, 13[A61K]
8,394,406 Once daily formulations of tetracyclinesDec 17, 10Mar 12, 13[A61K]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Filing Date Issue/Pub Date Intl Class
2013/0089,607 ONCE DAILY TROSPIUM CHLORIDE TREATMENT METHODSep 19, 12Apr 11, 13[A61K]
2011/0003,870 METHOD OF TREATMENT OF A NEUROLOGICAL DISORDERJun 30, 10Jan 06, 11[A61P, A61K]
2010/0221,352 PHARMACEUTICAL COMPOSITION FOR THE ONCE-A-DAY ORAL ADMINISTRATION OF TROSPIUM CHLORIDEMay 12, 10Sep 02, 10[A61P, A61K]
2010/0221,353 Pharmaceutical Composition For Once-A-Day Administration of Trospium ChlorideMay 12, 10Sep 02, 10[A61P, A61K]
2010/0221,354 PHARMACEUTICAL COMPOSITION FOR ONCE-A-DAY ORAL ADMINISTRATION OF TROSPIUM CHLORIDEMay 12, 10Sep 02, 10[A61P, A61K]
2010/0221,355 PHARMACEUTICAL COMPOSITION FOR ONCE-A-DAY ORAL ADMINISTRATION OF TROSPIUM CHLORIDEMay 12, 10Sep 02, 10[A61P, A61K]
2010/0221,356 PHARMACEUTICAL COMPOSITION FOR ONCE A DAY ADMINISTRATION OF TROSPIUM CHLORIDEMay 12, 10Sep 02, 10[A61P, A61K]
2010/0222,375 Pharmaceutical Composition Comprising Trospium Chloride for Once-A-Day AdministrationMay 12, 10Sep 02, 10[A61P, A61K]
2010/0209,489 Formulations of desvenlafaxineFeb 02, 10Aug 19, 10[A61P, A61K]
2010/0173,907 Method of treatment of aggressionDec 18, 09Jul 08, 10[A61P, A61K]
2010/0069,390 Method of treatment of attention deficit/hyperactivity disorder (ADHD)Sep 04, 09Mar 18, 10[A61P, A61K]
2007/0249,537 ABSORPTION ENHANCING AGENTSApr 27, 07Oct 25, 07[A61P, A61K]
2007/0134,315 Orally administrable extended release pellet and tablet formulations of a highly water soluble compoundDec 08, 05Jun 14, 07[A61K]
2007/0104,782 Modified release tablet formulations with enhanced mechanical propertiesJul 28, 06May 10, 07[A61K]
2006/0210,625 Sustained release of positively charged pharmacologically active molecules from a matrix containing polymers with polarized oxygen atomsNov 04, 04Sep 21, 06[A61K]
2005/0191,343 Micellar systems useful for delivery of lipophilic or hydrophobic compoundsNov 24, 04Sep 01, 05[A61K]
2004/0202,693 Pharmaceutical compositions releasing their active agents from a buccal or sublingual location to overcome an absorption window problemApr 13, 04Oct 14, 04[A61K]
2004/0167,203 Absorption enhancing agentsJan 22, 04Aug 26, 04[A61K]
2004/0062,800 Sustained release pharmaceutical dosage forms with minimized ph dependent dissolution profilesOct 21, 03Apr 01, 04[A61K]
2004/0028,729 Pharmaceutical formulations with improved bioavailabilityApr 29, 03Feb 12, 04[A61K]

View all patents..

Top Inventors for This Owner

Upgrade to the Premium Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.